11.19

0.86% 0.10

After Hours: 11.19

Perrigo Company Plc (PRGO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Perrigo Company Plc stock is traded at $11.19, with a volume of 3.75M. It is up +0.86% in the last 24 hours and up +3.28% over the past month. Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Previous Close:

$11.09

Open:

$11.19

24h Volume:

3.75M

Relative Volume:

1.15

Market Cap:

$1.55B

Revenue:

$4.18B

Net Income/Loss:

$-1.79B

P/E Ratio:

-0.8539

EPS:

-13.1048

Net Cash Flow:

$107.70M

1W Performance:

+7.65%

1M Performance:

+3.28%

6M Performance:

-23.34%

1Y Performance:

-58.17%

1-Day Range:

$11.05

$11.59

1-Week Range:

$10.21

$11.59

52-Week Range:

$9.225

$28.43

Perrigo Company Plc Stock (PRGO) Company Profile

Name

Perrigo Company Plc

Sector

Healthcare (1100)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

269-673-8451

Address

THE SHARP BUILDING, DUBLIN 2

Employee

8,100

Twitter

@perrigocompany

Next Earnings Date

2026-08-05

Latest SEC Filings

PRGO's Discussions on Twitter

Compare PRGO vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRGO Perrigo Company Plc	11.19	1.53B	4.18B	-1.79B	107.70M	-13.10
TAK Takeda Pharmaceutical Co Adr	16.96	53.37B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.84	42.80B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	34.65	41.09B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.29	31.62B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	563.70	23.23B	3.17B	1.29B	1.01B	27.09

Perrigo Company Plc Stock (PRGO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-06-25	Downgrade	JP Morgan	Overweight → Neutral
Jan-14-25	Downgrade	Argus	Buy → Hold
Jan-06-25	Downgrade	Piper Sandler	Overweight → Neutral
Sep-24-24	Resumed	Jefferies	Hold
Nov-17-23	Initiated	Piper Sandler	Overweight
Mar-07-23	Initiated	Canaccord Genuity	Buy
Sep-14-22	Upgrade	Argus	Hold → Buy
Sep-06-22	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-14-21	Upgrade	Raymond James	Mkt Perform → Outperform
Sep-30-21	Upgrade	Jefferies	Hold → Buy
Apr-07-21	Resumed	RBC Capital Mkts	Sector Perform
Jan-06-21	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Apr-17-20	Downgrade	Argus	Buy → Hold
Mar-24-20	Upgrade	JP Morgan	Neutral → Overweight
Mar-20-20	Upgrade	SVB Leerink	Mkt Perform → Outperform
Mar-18-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Oct-11-19	Upgrade	Argus	Hold → Buy
Mar-20-19	Initiated	SunTrust	Hold
Nov-13-18	Downgrade	Berenberg	Buy → Hold
Aug-10-18	Reiterated	Stifel	Hold
Jul-30-18	Downgrade	Argus	Buy → Hold
Jul-12-18	Downgrade	Goldman	Neutral → Sell
Jan-03-18	Initiated	Leerink Partners	Mkt Perform
Dec-08-17	Upgrade	Argus	Hold → Buy
Nov-10-17	Upgrade	RBC Capital Mkts	Underperform → Sector Perform
Oct-05-17	Reiterated	UBS	Buy
Sep-07-17	Initiated	Oppenheimer	Outperform
Aug-11-17	Upgrade	Goldman	Sell → Neutral
Aug-11-17	Reiterated	RBC Capital Mkts	Underperform
Jun-16-17	Initiated	Cantor Fitzgerald	Overweight
Jun-05-17	Downgrade	RBC Capital Mkts	Sector Perform → Underperform
Mar-03-17	Reiterated	B. Riley & Co.	Neutral

View All

Perrigo Company Plc Stock (PRGO) Latest News

03:23 AM

Enterprise value to revenue forward of Perrigo Company plc – NYSE:PRGO - TradingView

03:23 AM

Jul 06, 2026

Perrigo Company plc Files Form 8-K for NYSE-Listed Ordinary Shares and Senior Notes – Corporate Details and Security Listings – Minichart - Minichart

Jul 06, 2026

Perrigo (PRGO) details interim CEO Albert Manzone’s 2026 pay package - Stock Titan

Jul 06, 2026

Perrigo (PRGO) reinstates executive severance policy tied to CEO transition - Stock Titan

Jul 06, 2026

Jul 05, 2026

Jefferies lowers Perrigo stock price target to $14 on weak quarter - Investing.com

Jul 05, 2026

Jul 04, 2026

PRGOPerrigo Company plc Options - Finviz

Jul 04, 2026

The Store Brand Ibuprofen Tablets from PerrigoB2B pain reliever powering US pharmacy shelves - AD HOC NEWS

Jul 04, 2026

Jul 03, 2026